We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

December 2, 2014

Reckitt Benckiser Pharmaceuticals Inc. et al v. Dr. Reddy's Laboratories S.A., et al.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. September 1, 2017

    Dr. Reddy's Cleared Of Infringing Suboxone Patents

    Indivior PLC said Friday a Delaware federal judge found a product developed by Dr. Reddy’s Laboratories does not infringe three of its patents for Suboxone, clearing the way for a generic version of the opiate addiction treatment, which generates 80 percent of Indivior’s revenue.


To view the parties, register now.